Search results
Results from the WOW.Com Content Network
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals. [ 1 ] In September 2006, Merck KGaA announced its intent to purchase the majority of Serono shares from Ernesto Bertarelli and the Bertarelli family.
The new entity, which merges Serono with Merck's Ethicals division, is called Merck Serono. Its headquarters was in Geneva, within the new Serono facilities. The US operations remain near Boston and was renamed here EMD Serono due to trademark issues with Merck & Co./MSD. The process of merging started in January 2007 after various business ...
This followed her role as Senior Vice President and Head of Intercontinental Region, across the Middle East, Africa, and Russia/CIS countries. Before she joined Menarini Group, Elcin was based in Boston [ 5 ] [ 8 ] for three years as Executive Vice President, [ 5 ] Head of New Businesses [ 5 ] [ 8 ] at Merck Healthcare.
For premium support please call: 800-290-4726 more ways to reach us
Need help? Call us! 800-290-4726 Login / Join. Mail
Efalizumab (brand name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis.As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection.
Merck Serono (known as EMD Serono in the United States and Canada), a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals Merck & Co. , Inc. (known as MSD ( Merck Sharp & Dohme ) outside North America), an American pharmaceutical company and a former subsidiary of the ...
Cetrorelix is marketed by Merck Serono for use in in-vitro fertilization in all countries except Japan, where it is marketed by Shionogi and Nippon Kayaku. [4] Aeterna Zentaris receives royalties on these sales and retains rights to develop cetrorelix for other indications.